Skip to content

Fighting to Preserve the Benefits of the 340B Program

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles

RWC-340B Applauds Newly Reformulated Senate 340B Bipartisan Working Group

Congress, News, RWC-340BBy Amber TynanMarch 31, 2025

RWC-340B Applauds Newly Reformulated Senate 340B Bipartisan Working Group Bipartisan Working Group includes U.S. Senators Tammy Baldwin (D-Wis.), John Hickenlooper (D-Colo.), Tim Kaine (D-Va.), Shelley Moore Capito (R-W.V.), Jerry Moran…

340B ACCESS Act Harms Persons Living with HIV/AIDS

Congress, HIV/AIDS, HIV/AIDS Strategy, RWC-340BBy Amber TynanJuly 24, 2024

RWC-340B Fact Sheet – Oppose 340B ACCESS Act  

RWC-340B Signs Onto Joint Letter Providing Draft Guidance on the Inflation Reduction Act (IRA)

Congress, News, RWC-340BBy Amber TynanJuly 15, 2024

RWC-340B was asked to sign onto the attached letter to CMS commenting on its May 3, 2024 Draft Guidance implementing aspects of the Inflation Reduction Act (IRA). 340B Health drafted the…

RWC-340B Submits Comments to Senate 340B Working Group

Congress, HIV/AIDS Strategy, News, RWC-340BBy Amber TynanApril 18, 2024

RWC-340B carefully reviewed the draft legislation, explanatory statement, and supplemental request for information (RFI) that the Bipartisan 340B Senate Working Group (Working Group) shared with 340B stakeholders on February 2,…

Senate Working Group Releases SUSTAIN Act Discussion Draft of 340B Legislation

Congress, News, RWC-340BBy Amber TynanFebruary 5, 2024

RWC-340B welcomes the release of the bipartisan Senate Working Group on 340B’s legislative discussion draft of the “SUSTAIN 340B Act.” The draft bill – formally titled, the Supporting Underserved and Strengthening…

Senate Finance Letter Re: Opposition to 340B Covered Entity Reporting Requirement Language

Congress, NewsBy Amber TynanDecember 19, 2023

   

Gilead

RWC-340B Sends Letters to Gilead, HHS Secretary, and OPA Director.

Congress, Drug Pricing, HHS, HRSA, Regulations, RWC-340BBy Amber TynanApril 15, 2022

A growing number of pharmaceutical manufacturers have recently posed restrictions affecting Ryan White Clinics and other Safety Net Providers. RWC-340B has taken action to address these challenges head-on.   On…

Johnson Johnson Logo

Johnson & Johnson is the 16th Manufacturer to Restrict Access to 340B Prices at Contract Pharmacies

Congress, Drug Pricing, News, RWC-340BBy Amber TynanMarch 23, 2022

By letter dated March 21, 2021, Johnson & Johnson (J&J) announced that, effective May 2, 2022, it will no longer honor bill-to/ship-to orders for contract pharmacy arrangements with hospitals unless…

hammer ge8ffaccd3 1920

Rep. Matt Rosendale Introduces Legislation: DSH 340B Eligibility Moratorium, Regulations Limiting Such Eligibility, and Increased Reporting Requirements

Congress, Drug Pricing, HRSA, News, RegulationsBy Andrea JeriaOctober 11, 2021

On September 30, U.S. Representative Matt Rosendale (R-MT) introduced the Drug Pricing Transparency and Accountability Act (H.R. 5463), which would amend the 340B statute to add a two-year moratorium on…

financial gf32557403 1920

Senator Braun (R-IN) Introduces Legislation to Authorize HHS to Audit 340B Income

Congress, Drug Pricing, HHS, HRSA, News, RegulationsBy Andrea JeriaSeptember 27, 2021

On September 23, U.S. Senator Mike Braun (R-IN) introduced a bill to amend the 340B statute to allow HHS to audit 340B covered entities to determine how they use “net…

→12345…
67
8→
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »